| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50400-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2750-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50600-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50424-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47897-0.1mg | |||
![Immunohistochemistry: p53 [p Ser392] Antibody (FP3.2 [FPS392]) [NB500-575] - Wild-type p53 expressed in human trophoblast (paraffin-embedded sections). 1A - anti-p53 (total).](http://images.novusbio.com/fullsize/p53-p-Ser392-Antibody-FP3-2-FPS392-Immunohistochemistry-NB500-575-img0005.jpg "Immunohistochemistry: p53 [p Ser392] Antibody (FP3.2 [FPS392]) [NB500-575] - Wild-type p53 expressed in human trophoblast (paraffin-embedded sections). 1A - anti-p53 (total).")
![Immunohistochemistry: p53 [p Ser392] Antibody (FP3.2 [FPS392]) [NB500-575] - 1B anti-P53 (phospho Ser392) Note that some of total p53 positive nuclei are also FP3.2 (phospho p53) positive.](http://images.novusbio.com/fullsize/p53-p-Ser392-Antibody-FP3-2-FPS392-Immunohistochemistry-NB500-575-img0004.jpg)
![Western Blot: HP1 alpha Antibody [NBP2-59224] - Western blot was performed on nuclear extracts from HeLa cells (20 ug) with the antibody against human HP1 alpha, diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The molecular weight marker (kDa) is shown on the left; the expected location of HP1 alpha, HP1 beta and HP1 gamma is indicated on the right. The Western blot analysis clearly demonstrates that the HP1 alpha antibody specifically recognizes HP1 alpha and not HP1 beta and HP1 gamma.](http://images.novusbio.com/fullsize/HP1-alpha-Antibody-Western-Blot-NBP2-59224-img0003.jpg "Western Blot: HP1 alpha Antibody [NBP2-59224] - Western blot was performed on nuclear extracts from HeLa cells (20 ug) with the antibody against human HP1 alpha, diluted 1:1,000 in TBS-Tween containing 5% skimmed milk. The molecular weight marker (kDa) is shown on the left; the expected location of HP1 alpha, HP1 beta and HP1 gamma is indicated on the right. The Western blot analysis clearly demonstrates that the HP1 alpha antibody specifically recognizes HP1 alpha and not HP1 beta and HP1 gamma.")
![Immunocytochemistry/Immunofluorescence: HP1 alpha Antibody [NBP2-59224] - HeLa cells were stained with the antibody against HP1alpha and with DAPI. Cells were fixed with 4% formaldehyde for 10' and blocked with PBS/TX-100 containing 5% normal goat serum and 1% BSA. The cells were immunofluorescently labelled with the HP1alpha antibody (left) diluted 1:500 in blocking solution followed by an anti-rabbit antibody conjugated to Alexa Fluor 488. The middle panel shows staining of the nuclei with DAPI. A merge of the two stainings is shown on the right.](http://images.novusbio.com/fullsize/HP1-alpha-Antibody-Immunofluorescence-NBP2-59224-img0001.jpg)
![Western Blot: Timeless Antibody [H00008914-B01P] - Analysis of TIMELESS expression in transfected 293T cell line by TIMELESS polyclonal antibody. Lane 1: TIMELESS transfected lysate(132.88 KDa). Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/Timeless-Antibody-Western-Blot-H00008914-B01P-img0004.jpg "Western Blot: Timeless Antibody [H00008914-B01P] - Analysis of TIMELESS expression in transfected 293T cell line by TIMELESS polyclonal antibody. Lane 1: TIMELESS transfected lysate(132.88 KDa). Lane 2: Non-transfected lysate.")
![Immunocytochemistry/Immunofluorescence: Timeless Antibody [H00008914-B01P] - Analysis of purified antibody to TIMELESS on HeLa cell. (antibody concentration 10 ug/ml)](http://images.novusbio.com/fullsize/Timeless-Antibody-Immunocytochemistry-Immunofluorescence-H00008914-B01P-img0003.jpg)
![Western Blot: NCOA6 Antibody (2D7) [H00023054-M01] - NCOA6 monoclonal antibody (M01), clone 2D7 Analysis of NCOA6 expression in Hela S3 NE.](http://images.novusbio.com/fullsize/NCOA6-Antibody-2D7-Western-Blot-H00023054-M01-img0005.jpg "Western Blot: NCOA6 Antibody (2D7) [H00023054-M01] - NCOA6 monoclonal antibody (M01), clone 2D7 Analysis of NCOA6 expression in Hela S3 NE.")
![Immunocytochemistry/Immunofluorescence: NCOA6 Antibody (2D7) [H00023054-M01] - Analysis of monoclonal antibody to NCOA6 on HeLa cell. Antibody concentration 10 ug/ml.](http://images.novusbio.com/fullsize/NCOA6-Antibody-2D7-Immunocytochemistry-Immunofluorescence-H00023054-M01-img0004.jpg)
![Western Blot: c-Abl Antibody (M209) [NBP3-23312] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23312_mouse-c-abl-mab-m209-9820231138390.jpg "Western Blot: c-Abl Antibody (M209) [NBP3-23312] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).")
![Western Blot: c-Abl Antibody (M209) [NBP3-23312] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23312_mouse-c-abl-mab-m209-19920231915412.jpg)
![Western Blot: c-Abl [p Tyr412] Antibody [NBP3-23318] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).](http://images.novusbio.com/fullsize/nbp3-23318_rabbit-c-abl-p-tyr412-pab-19920231915414.jpg "Western Blot: c-Abl [p Tyr412] Antibody [NBP3-23318] - Western blot analysis of K-562 cells treated with pervanadate (1 mM) for 30 minutes (lanes 1, 3, & 5). Some lanes were treated with alkaline phosphatase to remove phosphorylation on c-Abl (lanes 2, 4, & 6), then the blots were probed with anti-c-Abl (lanes 1 & 2), anti-c-Abl (Tyr-412) (NBP3-23318; lanes 3 & 4), or anti-c-Abl (Tyr-245) (NBP3-23313; lanes 5 & 6).")
![Western Blot: FANCE Antibody (L5-P1E6G5) [NBP2-50400] - Detection of FANCE in a Jurkat cell lysate.](http://images.novusbio.com/fullsize/FANCE-Antibody-L5-P1E6G5-Western-Blot-NBP2-50400-img0001.jpg "Western Blot: FANCE Antibody (L5-P1E6G5) [NBP2-50400] - Detection of FANCE in a Jurkat cell lysate.")
![Immunohistochemistry: FANCE Antibody (L5-P1E6G5) [NBP2-50400] - Staining of human hepatocellular carcinoma shows both cytoplasmic and nuclear positivity but predominately cytoplasmic staining. IHC was performed on formalin-fixed, paraffin embedded tissue sections.](http://images.novusbio.com/fullsize/FANCE-Antibody-L5-P1E6G5-Immunohistochemistry-NBP2-50400-img0002.jpg)
![Western Blot: hnRNP K Antibody (N10 P2D3G2) [NBP2-50424] - Detection of hnRNP K isoform 1, a strong band at 51 kDa is observed.](http://images.novusbio.com/fullsize/hnRNP-K-Antibody-N10-P2D3G2-Western-Blot-NBP2-50424-img0001.jpg "Western Blot: hnRNP K Antibody (N10 P2D3G2) [NBP2-50424] - Detection of hnRNP K isoform 1, a strong band at 51 kDa is observed.")
![Immunohistochemistry: hnRNP K Antibody (N10 P2D3G2) [NBP2-50424] - Staining of formalin-fixed, paraffin-embedded tissue sections. Strong nuclear immunostaining was observed in normal skin (A). Nuclear and cytoplasmic immunostaining was observed in breast carcinoma (B). This is in agreement with existing literature as hnRNPK shows aberrant localisation in tumours.](http://images.novusbio.com/fullsize/hnRNP-K-Antibody-N10-P2D3G2-Immunohistochemistry-NBP2-50424-img0002.jpg)
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2) - IHC-Prediluted [NBP2-48384] - Formalin-fixed, paraffin-embedded human Bladder Carcinoma stained with p21 Mouse Monoclonal Antibody (CIP1/823 + DCS-60.2).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-823-+-DCS-60-2-IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48384-img0001.jpg "Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2) - IHC-Prediluted [NBP2-48384] - Formalin-fixed, paraffin-embedded human Bladder Carcinoma stained with p21 Mouse Monoclonal Antibody (CIP1/823 + DCS-60.2).")